Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-115504
Filing Date
2023-04-25
Accepted
2023-04-25 17:06:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d439021ddefa14a.htm DEFA14A 12345
2 GRAPHIC g439021g07v28.jpg GRAPHIC 375378
3 GRAPHIC g439021g93z07.jpg GRAPHIC 414170
  Complete submission text file 0001193125-23-115504.txt   1101289
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33038 | Film No.: 23845747
SIC: 2834 Pharmaceutical Preparations